Sign In
to Vote &
Create Storyboards.
 
The chief executive of Valeant Pharmaceuticals said that a short-seller's allegation that the company inflated its revenue was "completely untrue."
3
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard